• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
ANI Pharmaceuticals Executives Sell Shares and Report Strong Earnings
02:12
Nov7
ANI Pharma released FY2025 Q3 earnings on November 7 Pre-Market (EST), actual revenue USD 227.81 M (forecast USD 212.85 M), actual EPS USD 1.133 (forecast USD 0.36)
14:30
ANI Pharma released FY2025 9 Months Earnings on November 7 Pre-Market EST, with actual revenue of USD 636.31 M and EPS of USD 2.1799
14:30
Oct31
ANI Pharma to release FY2025 Q3 earnings report on November 7 During-Market EST, forecast revenue USD 212.85 M, EPS USD 0.36
00:14
Oct15
Analyst Khurshid Recommends BUY Rating on ANI Pharmaceuticals Stock
15:37
Sep26
Folkes and JPMorgan Maintain Buy Rating on ANI Pharmaceuticals
05:51

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 227.81 M, Net Income 23.79 M, EPS 1.133

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 211.37 M, Net Income 7.323 M, EPS 0.3614

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 197.12 M, Net Income 13.71 M, EPS 0.6855

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More